Richard Kovacs to Follow-Up Studies
This is a "connection" page, showing publications Richard Kovacs has written about Follow-Up Studies.
Connection Strength
0.133
-
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia. Br J Haematol. 2019 04; 185(2):232-239.
Score: 0.025
-
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden. Lancet Haematol. 2018 Aug; 5(8):e368-e377.
Score: 0.024
-
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. JAMA Cardiol. 2017 04 01; 2(4):370-380.
Score: 0.022
-
Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography. Circulation. 2014 Mar 25; 129(12):1310-9.
Score: 0.018
-
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1519-1528.
Score: 0.012
-
Effect of Aspirin on Disability-free Survival in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1499-1508.
Score: 0.012
-
Effect of PR interval prolongation on long-term outcomes in patients with left bundle branch block vs non-left bundle branch block morphologies undergoing cardiac resynchronization therapy. Heart Rhythm. 2017 10; 14(10):1523-1528.
Score: 0.011
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011 Jun 25; 377(9784):2181-92.
Score: 0.007